Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients
Objectives: The aim of this work was to perform a systematic review assessing the pharmacokinetic/pharmacodynamic (PK/PD) properties of dalbavancin and the clinical use for in-label and off-label indications in pediatric patients. Methods: Two authors independently searched the PubMed-MEDLINE and Sc...
Saved in:
| Main Authors: | Désirée Caselli, Maurizio Aricò, Elio Castagnola, Milo Gatti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/2/121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Off-Label Use of Dalbavancin in <i>Enterococcus</i> spp. Abscess and <i>Streptococcus pneumoniae</i> Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report
by: Miriam Banoub Morkos, et al.
Published: (2024-09-01) -
Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment
by: Giammarco Baiardi, et al.
Published: (2025-02-01) -
Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study
by: Alessandra Oliva, et al.
Published: (2025-01-01) -
The use of 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to central venous catheterization in infants: a national survey of the Italian Society of Neonatology
by: Vito D’Andrea, et al.
Published: (2025-06-01) -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY
by: Rola Husni, et al.
Published: (2021-04-01)